MELANOMA STAGE III
Clinical trials for MELANOMA STAGE III explained in plain language.
Never miss a new study
Get alerted when new MELANOMA STAGE III trials appear
Sign up with your email to follow new studies for MELANOMA STAGE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to unleash immune system against skin cancer
Disease control OngoingThis early-stage study is testing a new oral drug called SX-682 in people with advanced melanoma that has spread. The goal is to see if SX-682 can safely block certain cells that shield the tumor, allowing the patient's own immune system, boosted by an existing immunotherapy drug…
Matched conditions: MELANOMA STAGE III
Phase: PHASE1 • Sponsor: Syntrix Biosystems, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New vaccine combo aims to boost Body's fight against advanced skin cancer
Disease control OngoingThis study is testing whether adding one of two experimental cancer vaccines (SCIB1 or iSCIB1+) to standard immunotherapy drugs can help people with advanced, inoperable melanoma. The goal is to see if the vaccines make the standard treatments work better and longer for patients.…
Matched conditions: MELANOMA STAGE III
Phase: PHASE2 • Sponsor: Scancell Ltd • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
One shot before surgery guides Year-Long fight against skin cancer
Disease control OngoingThis study is testing a personalized approach to prevent melanoma skin cancer from coming back after surgery. Patients first get one dose of a drug (nivolumab) before their operation. Based on how the tumor responds to that single dose, doctors then assign a specific year-long dr…
Matched conditions: MELANOMA STAGE III
Phase: PHASE2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug duo aims to shrink tumors before melanoma surgery
Disease control OngoingThis study is testing whether giving two drugs—pembrolizumab and lenvatinib—for six weeks before surgery can better control stage III melanoma. The goal is to shrink the tumor and boost the body's immune response to improve long-term results after the operation. It involves 21 ad…
Matched conditions: MELANOMA STAGE III
Phase: PHASE2 • Sponsor: Melanoma Institute Australia • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New copycat cancer drug enters human testing
Disease control OngoingThis study is testing a new, similar version of the cancer drug Keytruda (called FYB206) to see if it behaves the same way in the body. It involves patients with stage IIB/IIC or III melanoma who have had their cancer completely removed by surgery. The main goal is to check if th…
Matched conditions: MELANOMA STAGE III
Phase: PHASE1 • Sponsor: Formycon AG • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New scan could predict if immunotherapy will wipe out melanoma before surgery
Disease control OngoingThis study is testing whether giving two immunotherapy drugs (nivolumab and ipilimumab) before surgery can shrink melanoma tumors and prevent the cancer from coming back. It involves 28 adults with stage III melanoma that can be surgically removed. The research also explores a ne…
Matched conditions: MELANOMA STAGE III
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New hope for cancer patients suffering devastating drug side effect
Disease control OngoingThis study tests whether the drug infliximab works better than standard steroid treatment to control severe colon inflammation (colitis) caused by cancer immunotherapy drugs. The trial involves 42 adults with advanced skin cancer who developed this serious side effect while recei…
Matched conditions: MELANOMA STAGE III
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Double attack on melanoma: trial tests powerful drug combo before surgery
Disease control OngoingThis study compares two immunotherapy approaches given before surgery for advanced melanoma that can still be removed. Patients receive either one immunotherapy drug or a combination of two drugs for 6 weeks before their operation, followed by additional treatment afterward. The …
Matched conditions: MELANOMA STAGE III
Phase: PHASE2 • Sponsor: Diwakar Davar • Aim: Disease control
Last updated Mar 18, 2026 18:25 UTC